A novel DNA-based therapy combined with gemcitabine chemotherapy has demonstrated encouraging survival outcomes in patients with platinum-resistant...

A randomised phase III trial published in Nature Medicine has reported an association between the timing of immunochemotherapy administration and...

A randomised phase III trial published in Nature Medicine has reported an association between the timing of immunochemotherapy administration and...

Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new...

Atara renegotiates one-time milestone payment with HCRx THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader...

Atara renegotiates one-time milestone payment with HCRx THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader...

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and...

The addition of the CDK4/6 inhibitor palbociclib to standard maintenance therapy significantly improved progression-free survival in patients with...

PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that...

SUNDAY, Feb. 15, 2026 — Chemotherapy is one of the most common weapons in the cancer-treatment arsenal, but its side effects are well known.Hair...